Serveur d'exploration Covid et maladies cardiovasculaires

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.

Identifieur interne : 000139 ( Main/Corpus ); précédent : 000138; suivant : 000140

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.

Auteurs : Andrew Clark ; Mark Jit ; Charlotte Warren-Gash ; Bruce Guthrie ; Harry H X. Wang ; Stewart W. Mercer ; Colin Sanderson ; Martin Mckee ; Christopher Troeger ; Kanyin L. Ong ; Francesco Checchi ; Pablo Perel ; Sarah Joseph ; Hamish P. Gibbs ; Amitava Banerjee ; Rosalind M. Eggo

Source :

RBID : pubmed:32553130

English descriptors

Abstract

BACKGROUND

The risk of severe COVID-19 if an individual becomes infected is known to be higher in older individuals and those with underlying health conditions. Understanding the number of individuals at increased risk of severe COVID-19 and how this varies between countries should inform the design of possible strategies to shield or vaccinate those at highest risk.

METHODS

We estimated the number of individuals at increased risk of severe disease (defined as those with at least one condition listed as "at increased risk of severe COVID-19" in current guidelines) by age (5-year age groups), sex, and country for 188 countries using prevalence data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 and UN population estimates for 2020. The list of underlying conditions relevant to COVID-19 was determined by mapping the conditions listed in GBD 2017 to those listed in guidelines published by WHO and public health agencies in the UK and the USA. We analysed data from two large multimorbidity studies to determine appropriate adjustment factors for clustering and multimorbidity. To help interpretation of the degree of risk among those at increased risk, we also estimated the number of individuals at high risk (defined as those that would require hospital admission if infected) using age-specific infection-hospitalisation ratios for COVID-19 estimated for mainland China and making adjustments to reflect country-specific differences in the prevalence of underlying conditions and frailty. We assumed males were twice at likely as females to be at high risk. We also calculated the number of individuals without an underlying condition that could be considered at increased risk because of their age, using minimum ages from 50 to 70 years. We generated uncertainty intervals (UIs) for our estimates by running low and high scenarios using the lower and upper 95% confidence limits for country population size, disease prevalences, multimorbidity fractions, and infection-hospitalisation ratios, and plausible low and high estimates for the degree of clustering, informed by multimorbidity studies.

FINDINGS

We estimated that 1·7 billion (UI 1·0-2·4) people, comprising 22% (UI 15-28) of the global population, have at least one underlying condition that puts them at increased risk of severe COVID-19 if infected (ranging from <5% of those younger than 20 years to >66% of those aged 70 years or older). We estimated that 349 million (186-787) people (4% [3-9] of the global population) are at high risk of severe COVID-19 and would require hospital admission if infected (ranging from <1% of those younger than 20 years to approximately 20% of those aged 70 years or older). We estimated 6% (3-12) of males to be at high risk compared with 3% (2-7) of females. The share of the population at increased risk was highest in countries with older populations, African countries with high HIV/AIDS prevalence, and small island nations with high diabetes prevalence. Estimates of the number of individuals at increased risk were most sensitive to the prevalence of chronic kidney disease, diabetes, cardiovascular disease, and chronic respiratory disease.

INTERPRETATION

About one in five individuals worldwide could be at increased risk of severe COVID-19, should they become infected, due to underlying health conditions, but this risk varies considerably by age. Our estimates are uncertain, and focus on underlying conditions rather than other risk factors such as ethnicity, socioeconomic deprivation, and obesity, but provide a starting point for considering the number of individuals that might need to be shielded or vaccinated as the global pandemic unfolds.

FUNDING

UK Department for International Development, Wellcome Trust, Health Data Research UK, Medical Research Council, and National Institute for Health Research.


DOI: 10.1016/S2214-109X(20)30264-3
PubMed: 32553130
PubMed Central: PMC7295519

Links to Exploration step

pubmed:32553130

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.</title>
<author>
<name sortKey="Clark, Andrew" sort="Clark, Andrew" uniqKey="Clark A" first="Andrew" last="Clark">Andrew Clark</name>
<affiliation>
<nlm:affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: andrew.clark@lshtm.ac.uk.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jit, Mark" sort="Jit, Mark" uniqKey="Jit M" first="Mark" last="Jit">Mark Jit</name>
<affiliation>
<nlm:affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Warren Gash, Charlotte" sort="Warren Gash, Charlotte" uniqKey="Warren Gash C" first="Charlotte" last="Warren-Gash">Charlotte Warren-Gash</name>
<affiliation>
<nlm:affiliation>Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Guthrie, Bruce" sort="Guthrie, Bruce" uniqKey="Guthrie B" first="Bruce" last="Guthrie">Bruce Guthrie</name>
<affiliation>
<nlm:affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wang, Harry H X" sort="Wang, Harry H X" uniqKey="Wang H" first="Harry H X" last="Wang">Harry H X. Wang</name>
<affiliation>
<nlm:affiliation>School of Public Health, Sun Yat-Sen University, Guangzhou, China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mercer, Stewart W" sort="Mercer, Stewart W" uniqKey="Mercer S" first="Stewart W" last="Mercer">Stewart W. Mercer</name>
<affiliation>
<nlm:affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sanderson, Colin" sort="Sanderson, Colin" uniqKey="Sanderson C" first="Colin" last="Sanderson">Colin Sanderson</name>
<affiliation>
<nlm:affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mckee, Martin" sort="Mckee, Martin" uniqKey="Mckee M" first="Martin" last="Mckee">Martin Mckee</name>
<affiliation>
<nlm:affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Troeger, Christopher" sort="Troeger, Christopher" uniqKey="Troeger C" first="Christopher" last="Troeger">Christopher Troeger</name>
<affiliation>
<nlm:affiliation>Department for Health Metrics, University of Washington, Seattle, WA, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ong, Kanyin L" sort="Ong, Kanyin L" uniqKey="Ong K" first="Kanyin L" last="Ong">Kanyin L. Ong</name>
<affiliation>
<nlm:affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Checchi, Francesco" sort="Checchi, Francesco" uniqKey="Checchi F" first="Francesco" last="Checchi">Francesco Checchi</name>
<affiliation>
<nlm:affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Perel, Pablo" sort="Perel, Pablo" uniqKey="Perel P" first="Pablo" last="Perel">Pablo Perel</name>
<affiliation>
<nlm:affiliation>Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Joseph, Sarah" sort="Joseph, Sarah" uniqKey="Joseph S" first="Sarah" last="Joseph">Sarah Joseph</name>
<affiliation>
<nlm:affiliation>IAVI Human Immunology Laboratory, Imperial College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gibbs, Hamish P" sort="Gibbs, Hamish P" uniqKey="Gibbs H" first="Hamish P" last="Gibbs">Hamish P. Gibbs</name>
<affiliation>
<nlm:affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Banerjee, Amitava" sort="Banerjee, Amitava" uniqKey="Banerjee A" first="Amitava" last="Banerjee">Amitava Banerjee</name>
<affiliation>
<nlm:affiliation>Institute of Health Informatics, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Eggo, Rosalind M" sort="Eggo, Rosalind M" uniqKey="Eggo R" first="Rosalind M" last="Eggo">Rosalind M. Eggo</name>
<affiliation>
<nlm:affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32553130</idno>
<idno type="pmid">32553130</idno>
<idno type="doi">10.1016/S2214-109X(20)30264-3</idno>
<idno type="pmc">PMC7295519</idno>
<idno type="wicri:Area/Main/Corpus">000139</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000139</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.</title>
<author>
<name sortKey="Clark, Andrew" sort="Clark, Andrew" uniqKey="Clark A" first="Andrew" last="Clark">Andrew Clark</name>
<affiliation>
<nlm:affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: andrew.clark@lshtm.ac.uk.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jit, Mark" sort="Jit, Mark" uniqKey="Jit M" first="Mark" last="Jit">Mark Jit</name>
<affiliation>
<nlm:affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Warren Gash, Charlotte" sort="Warren Gash, Charlotte" uniqKey="Warren Gash C" first="Charlotte" last="Warren-Gash">Charlotte Warren-Gash</name>
<affiliation>
<nlm:affiliation>Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Guthrie, Bruce" sort="Guthrie, Bruce" uniqKey="Guthrie B" first="Bruce" last="Guthrie">Bruce Guthrie</name>
<affiliation>
<nlm:affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wang, Harry H X" sort="Wang, Harry H X" uniqKey="Wang H" first="Harry H X" last="Wang">Harry H X. Wang</name>
<affiliation>
<nlm:affiliation>School of Public Health, Sun Yat-Sen University, Guangzhou, China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mercer, Stewart W" sort="Mercer, Stewart W" uniqKey="Mercer S" first="Stewart W" last="Mercer">Stewart W. Mercer</name>
<affiliation>
<nlm:affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sanderson, Colin" sort="Sanderson, Colin" uniqKey="Sanderson C" first="Colin" last="Sanderson">Colin Sanderson</name>
<affiliation>
<nlm:affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mckee, Martin" sort="Mckee, Martin" uniqKey="Mckee M" first="Martin" last="Mckee">Martin Mckee</name>
<affiliation>
<nlm:affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Troeger, Christopher" sort="Troeger, Christopher" uniqKey="Troeger C" first="Christopher" last="Troeger">Christopher Troeger</name>
<affiliation>
<nlm:affiliation>Department for Health Metrics, University of Washington, Seattle, WA, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ong, Kanyin L" sort="Ong, Kanyin L" uniqKey="Ong K" first="Kanyin L" last="Ong">Kanyin L. Ong</name>
<affiliation>
<nlm:affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Checchi, Francesco" sort="Checchi, Francesco" uniqKey="Checchi F" first="Francesco" last="Checchi">Francesco Checchi</name>
<affiliation>
<nlm:affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Perel, Pablo" sort="Perel, Pablo" uniqKey="Perel P" first="Pablo" last="Perel">Pablo Perel</name>
<affiliation>
<nlm:affiliation>Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Joseph, Sarah" sort="Joseph, Sarah" uniqKey="Joseph S" first="Sarah" last="Joseph">Sarah Joseph</name>
<affiliation>
<nlm:affiliation>IAVI Human Immunology Laboratory, Imperial College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gibbs, Hamish P" sort="Gibbs, Hamish P" uniqKey="Gibbs H" first="Hamish P" last="Gibbs">Hamish P. Gibbs</name>
<affiliation>
<nlm:affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Banerjee, Amitava" sort="Banerjee, Amitava" uniqKey="Banerjee A" first="Amitava" last="Banerjee">Amitava Banerjee</name>
<affiliation>
<nlm:affiliation>Institute of Health Informatics, University College London, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Eggo, Rosalind M" sort="Eggo, Rosalind M" uniqKey="Eggo R" first="Rosalind M" last="Eggo">Rosalind M. Eggo</name>
<affiliation>
<nlm:affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Lancet. Global health</title>
<idno type="eISSN">2214-109X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Chronic Disease (epidemiology)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Female (MeSH)</term>
<term>Global Health (statistics & numerical data)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Models, Statistical (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Risk Assessment (MeSH)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>United Kingdom (epidemiology)</term>
<term>United States (epidemiology)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>United Kingdom</term>
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Chronic Disease</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Global Health</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Models, Statistical</term>
<term>Pandemics</term>
<term>Risk Assessment</term>
<term>Severity of Illness Index</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>The risk of severe COVID-19 if an individual becomes infected is known to be higher in older individuals and those with underlying health conditions. Understanding the number of individuals at increased risk of severe COVID-19 and how this varies between countries should inform the design of possible strategies to shield or vaccinate those at highest risk.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>We estimated the number of individuals at increased risk of severe disease (defined as those with at least one condition listed as "at increased risk of severe COVID-19" in current guidelines) by age (5-year age groups), sex, and country for 188 countries using prevalence data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 and UN population estimates for 2020. The list of underlying conditions relevant to COVID-19 was determined by mapping the conditions listed in GBD 2017 to those listed in guidelines published by WHO and public health agencies in the UK and the USA. We analysed data from two large multimorbidity studies to determine appropriate adjustment factors for clustering and multimorbidity. To help interpretation of the degree of risk among those at increased risk, we also estimated the number of individuals at high risk (defined as those that would require hospital admission if infected) using age-specific infection-hospitalisation ratios for COVID-19 estimated for mainland China and making adjustments to reflect country-specific differences in the prevalence of underlying conditions and frailty. We assumed males were twice at likely as females to be at high risk. We also calculated the number of individuals without an underlying condition that could be considered at increased risk because of their age, using minimum ages from 50 to 70 years. We generated uncertainty intervals (UIs) for our estimates by running low and high scenarios using the lower and upper 95% confidence limits for country population size, disease prevalences, multimorbidity fractions, and infection-hospitalisation ratios, and plausible low and high estimates for the degree of clustering, informed by multimorbidity studies.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>FINDINGS</b>
</p>
<p>We estimated that 1·7 billion (UI 1·0-2·4) people, comprising 22% (UI 15-28) of the global population, have at least one underlying condition that puts them at increased risk of severe COVID-19 if infected (ranging from <5% of those younger than 20 years to >66% of those aged 70 years or older). We estimated that 349 million (186-787) people (4% [3-9] of the global population) are at high risk of severe COVID-19 and would require hospital admission if infected (ranging from <1% of those younger than 20 years to approximately 20% of those aged 70 years or older). We estimated 6% (3-12) of males to be at high risk compared with 3% (2-7) of females. The share of the population at increased risk was highest in countries with older populations, African countries with high HIV/AIDS prevalence, and small island nations with high diabetes prevalence. Estimates of the number of individuals at increased risk were most sensitive to the prevalence of chronic kidney disease, diabetes, cardiovascular disease, and chronic respiratory disease.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>INTERPRETATION</b>
</p>
<p>About one in five individuals worldwide could be at increased risk of severe COVID-19, should they become infected, due to underlying health conditions, but this risk varies considerably by age. Our estimates are uncertain, and focus on underlying conditions rather than other risk factors such as ethnicity, socioeconomic deprivation, and obesity, but provide a starting point for considering the number of individuals that might need to be shielded or vaccinated as the global pandemic unfolds.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>FUNDING</b>
</p>
<p>UK Department for International Development, Wellcome Trust, Health Data Research UK, Medical Research Council, and National Institute for Health Research.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32553130</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2214-109X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>The Lancet. Global health</Title>
<ISOAbbreviation>Lancet Glob Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.</ArticleTitle>
<Pagination>
<MedlinePgn>e1003-e1017</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S2214-109X(20)30264-3</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S2214-109X(20)30264-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND">The risk of severe COVID-19 if an individual becomes infected is known to be higher in older individuals and those with underlying health conditions. Understanding the number of individuals at increased risk of severe COVID-19 and how this varies between countries should inform the design of possible strategies to shield or vaccinate those at highest risk.</AbstractText>
<AbstractText Label="METHODS">We estimated the number of individuals at increased risk of severe disease (defined as those with at least one condition listed as "at increased risk of severe COVID-19" in current guidelines) by age (5-year age groups), sex, and country for 188 countries using prevalence data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 and UN population estimates for 2020. The list of underlying conditions relevant to COVID-19 was determined by mapping the conditions listed in GBD 2017 to those listed in guidelines published by WHO and public health agencies in the UK and the USA. We analysed data from two large multimorbidity studies to determine appropriate adjustment factors for clustering and multimorbidity. To help interpretation of the degree of risk among those at increased risk, we also estimated the number of individuals at high risk (defined as those that would require hospital admission if infected) using age-specific infection-hospitalisation ratios for COVID-19 estimated for mainland China and making adjustments to reflect country-specific differences in the prevalence of underlying conditions and frailty. We assumed males were twice at likely as females to be at high risk. We also calculated the number of individuals without an underlying condition that could be considered at increased risk because of their age, using minimum ages from 50 to 70 years. We generated uncertainty intervals (UIs) for our estimates by running low and high scenarios using the lower and upper 95% confidence limits for country population size, disease prevalences, multimorbidity fractions, and infection-hospitalisation ratios, and plausible low and high estimates for the degree of clustering, informed by multimorbidity studies.</AbstractText>
<AbstractText Label="FINDINGS">We estimated that 1·7 billion (UI 1·0-2·4) people, comprising 22% (UI 15-28) of the global population, have at least one underlying condition that puts them at increased risk of severe COVID-19 if infected (ranging from <5% of those younger than 20 years to >66% of those aged 70 years or older). We estimated that 349 million (186-787) people (4% [3-9] of the global population) are at high risk of severe COVID-19 and would require hospital admission if infected (ranging from <1% of those younger than 20 years to approximately 20% of those aged 70 years or older). We estimated 6% (3-12) of males to be at high risk compared with 3% (2-7) of females. The share of the population at increased risk was highest in countries with older populations, African countries with high HIV/AIDS prevalence, and small island nations with high diabetes prevalence. Estimates of the number of individuals at increased risk were most sensitive to the prevalence of chronic kidney disease, diabetes, cardiovascular disease, and chronic respiratory disease.</AbstractText>
<AbstractText Label="INTERPRETATION">About one in five individuals worldwide could be at increased risk of severe COVID-19, should they become infected, due to underlying health conditions, but this risk varies considerably by age. Our estimates are uncertain, and focus on underlying conditions rather than other risk factors such as ethnicity, socioeconomic deprivation, and obesity, but provide a starting point for considering the number of individuals that might need to be shielded or vaccinated as the global pandemic unfolds.</AbstractText>
<AbstractText Label="FUNDING">UK Department for International Development, Wellcome Trust, Health Data Research UK, Medical Research Council, and National Institute for Health Research.</AbstractText>
<CopyrightInformation>Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Clark</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: andrew.clark@lshtm.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jit</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Warren-Gash</LastName>
<ForeName>Charlotte</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guthrie</LastName>
<ForeName>Bruce</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Harry H X</ForeName>
<Initials>HHX</Initials>
<AffiliationInfo>
<Affiliation>School of Public Health, Sun Yat-Sen University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mercer</LastName>
<ForeName>Stewart W</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sanderson</LastName>
<ForeName>Colin</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McKee</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Troeger</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department for Health Metrics, University of Washington, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ong</LastName>
<ForeName>Kanyin L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Checchi</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Perel</LastName>
<ForeName>Pablo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joseph</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>IAVI Human Immunology Laboratory, Imperial College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gibbs</LastName>
<ForeName>Hamish P</ForeName>
<Initials>HP</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Banerjee</LastName>
<ForeName>Amitava</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eggo</LastName>
<ForeName>Rosalind M</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Acronym>WT_</Acronym>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>06</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Lancet Glob Health</MedlineTA>
<NlmUniqueID>101613665</NlmUniqueID>
<ISSNLinking>2214-109X</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Lancet Glob Health. 2020 Aug;8(8):e974-e975</RefSource>
<PMID Version="1">32553131</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Nightingale</LastName>
<ForeName>Emily S</ForeName>
<Initials>ES</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>O'Reilly</LastName>
<ForeName>Kathleen</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jombart</LastName>
<ForeName>Thibaut</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Edmunds</LastName>
<ForeName>W John</ForeName>
<Initials>WJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rosello</LastName>
<ForeName>Alicia</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Fiona Yueqian</ForeName>
<Initials>FY</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Atkins</LastName>
<ForeName>Katherine E</ForeName>
<Initials>KE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bosse</LastName>
<ForeName>Nikos I</ForeName>
<Initials>NI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Clifford</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Russell</LastName>
<ForeName>Timothy W</ForeName>
<Initials>TW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Deol</LastName>
<ForeName>Arminder K</ForeName>
<Initials>AK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Procter</LastName>
<ForeName>Simon R</ForeName>
<Initials>SR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leclerc</LastName>
<ForeName>Quentin J</ForeName>
<Initials>QJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Medley</LastName>
<ForeName>Graham</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Knight</LastName>
<ForeName>Gwen</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Munday</LastName>
<ForeName>James D</ForeName>
<Initials>JD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kucharski</LastName>
<ForeName>Adam J</ForeName>
<Initials>AJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pearson</LastName>
<ForeName>Carl A B</ForeName>
<Initials>CAB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Klepac</LastName>
<ForeName>Petra</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prem</LastName>
<ForeName>Kiesha</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Houben</LastName>
<ForeName>Rein M G J</ForeName>
<Initials>RMGJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Endo</LastName>
<ForeName>Akira</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Flasche</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Davies</LastName>
<ForeName>Nicholas G</ForeName>
<Initials>NG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diamond</LastName>
<ForeName>Charlie</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van Zandvoort</LastName>
<ForeName>Kevin</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Funk</LastName>
<ForeName>Sebastian</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Auzenbergs</LastName>
<ForeName>Megan</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rees</LastName>
<ForeName>Eleanor M</ForeName>
<Initials>EM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tully</LastName>
<ForeName>Damien C</ForeName>
<Initials>DC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Emery</LastName>
<ForeName>Jon C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Quilty</LastName>
<ForeName>Billy J</ForeName>
<Initials>BJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Abbott</LastName>
<ForeName>Sam</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Villabona-Arenas</LastName>
<ForeName>Ch Julian</ForeName>
<Initials>CJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hué</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hellewell</LastName>
<ForeName>Joel</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gimma</LastName>
<ForeName>Amy</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jarvis</LastName>
<ForeName>Christopher I</ForeName>
<Initials>CI</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>05</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>05</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32553130</ArticleId>
<ArticleId IdType="pii">S2214-109X(20)30264-3</ArticleId>
<ArticleId IdType="doi">10.1016/S2214-109X(20)30264-3</ArticleId>
<ArticleId IdType="pmc">PMC7295519</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000139 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000139 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CardioCovidV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32553130
   |texte=   Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32553130" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CardioCovidV1 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Aug 4 15:08:30 2020. Site generation: Wed Jan 27 11:23:02 2021